Algernon Pharmaceuticals Inc.
AGNPF
$0.06
-$0.003-4.76%
OTC PK
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 9.98% | -129.04% | 241.81% | -95.60% | 79.85% |
| Total Depreciation and Amortization | 2.56% | -13.33% | -21.05% | 5.56% | -46.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 294.12% | 100.25% | -1,315.38% | 91.11% | -95.32% |
| Change in Net Operating Assets | 150.93% | 84.11% | -324.83% | 61.47% | 35.30% |
| Cash from Operations | 61.59% | 64.75% | -636.65% | -364.49% | 91.09% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.17% | 9,943.02% | -- | -- |
| Cash from Investing | -- | -100.17% | 9,943.02% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.94% | 4,454.67% | -97.18% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.96% | 8,238.18% | -97.22% | -- | -- |
| Foreign Exchange rate Adjustments | 214.29% | -206.06% | 430.00% | -200.00% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,685.57% | -102.48% | 24,356.25% | 104.29% | 83.92% |